D. Xing

599 total citations
11 papers, 463 citations indexed

About

D. Xing is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Xing has authored 11 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Xing's work include Cancer Treatment and Pharmacology (4 papers), Diabetes and associated disorders (3 papers) and Cancer Genomics and Diagnostics (3 papers). D. Xing is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Diabetes and associated disorders (3 papers) and Cancer Genomics and Diagnostics (3 papers). D. Xing collaborates with scholars based in United States, United Kingdom and China. D. Xing's co-authors include Craig Kollman, Janet M. Allen, Stephanie A. Amiel, Jeffrey R. Harris, D. Elleri, Mark L. Evans, Marianna Nodale, Roman Hovorka, Helen Murphy and Malgorzata E. Wilinska and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Cancer Research.

In The Last Decade

D. Xing

10 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Xing United States 8 294 244 177 103 51 11 463
Pablo Valderrábano Spain 16 755 2.6× 433 1.8× 216 1.2× 46 0.4× 16 0.3× 35 799
Leo Guidobaldi Italy 15 612 2.1× 382 1.6× 72 0.4× 64 0.6× 14 0.3× 26 678
Jan Henrik Storkholm Denmark 13 150 0.5× 313 1.3× 33 0.2× 192 1.9× 73 1.4× 36 464
Fumihiro Uchikoshi Japan 11 38 0.1× 254 1.0× 92 0.5× 54 0.5× 97 1.9× 45 342
Isao Tabei Japan 9 249 0.8× 209 0.9× 34 0.2× 52 0.5× 32 0.6× 27 383
Verter Barbieri Italy 10 671 2.3× 612 2.5× 37 0.2× 42 0.4× 40 0.8× 14 780
Joana Simões‐Pereira Portugal 10 162 0.6× 57 0.2× 39 0.2× 59 0.6× 29 0.6× 38 270
Roberto Maria Romano Italy 8 120 0.4× 95 0.4× 20 0.1× 54 0.5× 24 0.5× 9 246
Jianwu Qin China 9 161 0.5× 169 0.7× 15 0.1× 57 0.6× 27 0.5× 27 298
Zhengang Xu China 9 137 0.5× 104 0.4× 25 0.1× 77 0.7× 29 0.6× 23 266

Countries citing papers authored by D. Xing

Since Specialization
Citations

This map shows the geographic impact of D. Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Xing more than expected).

Fields of papers citing papers by D. Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Xing. The network helps show where D. Xing may publish in the future.

Co-authorship network of co-authors of D. Xing

This figure shows the co-authorship network connecting the top 25 collaborators of D. Xing. A scholar is included among the top collaborators of D. Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Xing. D. Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Xing, D., Xin Chen, Yu Ma, et al.. (2025). Application of aromatherapy in patients with cognitive impairment: An integrative review. SHILAP Revista de lepidopterología. 7(2). 95–111.
2.
3.
Choueiri, Toni K., Masatoshi Eto, Evgeny Kopyltsov, et al.. (2021). 660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update. Annals of Oncology. 32. S683–S685. 19 indexed citations
4.
5.
Tolaney, SM, Kevin Kalinsky, Virginia Kaklamani, et al.. (2018). Abstract PD6-13: Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer. Cancer Research. 78(4_Supplement). PD6–13. 56 indexed citations
6.
7.
Tolaney, SM, et al.. (2017). Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer. European Journal of Cancer. 72. S16–S16. 31 indexed citations
8.
Haidar, Ahmad, Virginie Messier, D. Xing, et al.. (2014). Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus. Diabetes & Metabolism. 40(3). 211–214. 19 indexed citations
9.
Tansey, Michael, Lori M. Laffel, Jidong Cheng, et al.. (2011). Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabetic Medicine. 28(9). 1118–1122. 98 indexed citations
10.
Hovorka, Roman, Kavita Kumareswaran, Jeffrey R. Harris, et al.. (2011). Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ. 342(apr13 5). d1855–d1855. 193 indexed citations
11.
Kupersmith, Mark J., et al.. (2007). Visual function at baseline and 1 month in acute optic neuritis. Neurology. 69(6). 508–514. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pablo Valderrábano Breakdown of academic impact, for papers by Leo Guidobaldi Breakdown of academic impact, for papers by Jan Henrik Storkholm Breakdown of academic impact, for papers by Fumihiro Uchikoshi Breakdown of academic impact, for papers by Isao Tabei Breakdown of academic impact, for papers by Verter Barbieri Breakdown of academic impact, for papers by Joana Simões‐Pereira Breakdown of academic impact, for papers by Roberto Maria Romano Breakdown of academic impact, for papers by Jianwu Qin Breakdown of academic impact, for papers by Zhengang Xu
Rankless by CCL
2026